MADRID, 5 (EUROPA PRESS)

Biomedical company Pfizer is the company of the sector that best programs of corporate social responsibility has, according to the KAR 2011 study by IPSOS market research company. Therein, 24 percent of those surveyed supported the social work of Pfizer.

The study, which has been developed in the months of March, April and may, has counted on the collaboration of 300 professionals, including politicians, academics, business leaders and journalists. The goal of analysts has been measuring corporate reputation of the most important entities with presence in Spain.

Other information of interest which casts the document provided by IPSOS is that 69 percent of those interviewed considered Bayer signature with the best strategy in the sector. Pfizer obtained second place this time with 60 percent support, while Novartis precedes with 51 percent of recognition.

Company with better future

For the director of communication and Corporate Social responsibility of Pfizer, Francisco j. García Pascual, the actions of the company that represents “should be based on three basic principles: social responsibility, transparency and information to patients in health”. This has also had to respondents, that Pfizer is, according to the study, as the company with better prospects of future

Pfizer based social work on the foundation of the company, founded 12 years ago with the mission to “improve health education of the Spanish population, through the promotion of the concept of healthy ageing at any stage of life, as a natural process, to develop initiatives that recognize and support research”. In addition, organizes forums for debate and the delivery of its annual awards, which recognize the institutions or persons helping with their daily work to improve health.

Another of the objectives of the Pfizer Foundation is the training of health professionals and the sending of a wide range of resources to the improvement of health. Added to this, Pfizer stressed that from 2007 working with the Adecco Foundation for the integration of people with disabilities.

This pharmaceutical company also develops social elsewhere actions such as that of humanitarian cooperation. The Foundation, together with the Spanish Association of urology and the new men Foundation, helps people with kidney and Urologic.